Prastiya Indra Gunawan

Dr. Prastiya Indra Gunawan


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2019 in Korean Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
PGPrastiya Indra Gunawan
Prastiya Indra Gunawan
DSDarto Saharso
Darto Saharso
DSDian Purnama Sari
Dian Purnama Sari
To evaluate the association between elevated S100B levels with brain tissue damage seen in abnormalities of head magnetic resonance imaging (MRI; diffusion tensor imaging [DTI] sequence) in patients with status epilepticus (SE). An analytical observational study was conducted in children hospitalized at Dr Soetomo Hospital, Surabaya, from July to December 2016. The patients were divided into 2 groups: SE included all children with a history of SE; control included all children with febrile seizure. Blood samples of patients were drawn within 24 hours after admission. SE patients also underwent cranial MRI with additional DTI sequencing. The Mann-Whitney test and Spearman test were used for statistical analysis. Fifty-three patients were enrolled the study. In the 24 children with SE who met the inclusion criteria, serum S100B and cranial MRI findings were assessed. Twenty-two children admitted with febrile seizures became the control group. Most patients were male (66.7%); the mean age was 35.8 months (standard deviation, 31.09). Mean S100B values of the SE group (3.430±0.141 μg/L) and the control group (2.998±0.572 μg/L) were significantly different (P<0.05). A significant difference was noted among each level of encephalopathy based on the cranial MRI results with serum S100B levels and the correlation was strongly positive with a coefficient value of 0.758 (P<0.001). In SE patients, there is an increase of serum S100B levels within 24 hours after seizure, which has a strong positive correlation with brain damage seen in head MRI and DTI.

16 May 2016 in Ethiopian Journal of Health Sciences
Verified
Journal Article
Open access
PDF file
PGPrastiya Indra Gunawan
Prastiya Indra Gunawan
AIAreta Idarto
Areta Idarto
DSDarto Saharso
Darto Saharso
Acanthamoeba Infection in a Drowning Child

1 January 2017 in Korean Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
DPDian Pratamastuti
Dian Pratamastuti
PGPrastiya Indra Gunawan
Prastiya Indra Gunawan
DSDarto Saharso
Darto Saharso
Pratamastuti D, et al. Korean J Pediatr. 2017 Sep;60(9):302-306. https://doi.org/10.3345/kjp.2017.60.9.302

26 August 2023 in Epilepsy & Behavior Reports
Verified
Journal Article
Open access
PGPrastiya Indra Gunawan
Prastiya Indra Gunawan
NRNur Rochmah
Nur Rochmah
MFMuhammad Faizi
Muhammad Faizi
Treatment with antiseizure medications (ASMs) for more than 6 months requires monitoring of side effects, one of which is a decreased level of serum vitamin D. This study aimed to compare the influence of therapies with one versus multiple ASMs on 25-hydroxy vitamin D (25-OHD) levels among children with epilepsy. Our cross-sectional comparative study was conducted in the Paediatric Neurology Clinic at Soetomo Academic Hospital. Epileptic children aged 2–18 years who had been using ASMs for at least 6 months were enrolled and grouped according to whether they had been taking single or multiple ASMs. The mean 25-OHD levels of both groups were compared using a Welch t-test (95% confidence interval). Among the 60 children enrolled, vitamin D deficiency was identified in 13% of children taking a single ASM and in 53% of ones taking multiple ASMs; mean 25-OHD levels were 26.6 (SD 5.29) ng/mL and 20.2 (SD 4.25) ng/mL, respectively. There was a significant difference between the groups (p = 0.001). Patients taking single and multiple ASMs have lower 25-OHD levels than expected for their age, with those taking multiple ASMs having the lowest 25-OHD levels.

31 May 2017 in Acta Medica Academica
Verified
Journal Article
Open access
PGPrastiya Indra Gunawan
Prastiya Indra Gunawan

31 July 2022 in Biomedical Research and Therapy
Verified
Journal Article
Open access
PDF file
PGPrastiya Indra Gunawan
Prastiya Indra Gunawan
RNRiza Noviandi
Riza Noviandi
SSSunny Mariana Samosir
Sunny Mariana Samosir
Introduction: Acute brain injury caused by cerebral ischemia, either due to stroke or ischemic hypoxic-ischemic encephalopathy (HIE), represents a major neurological cause of death and disability worldwide. Neuronal cell injury has been shown to correlate with a significant increase in neuron-specific enolase (NSE) levels in in vitro studies. This study aims to measure NSE levels in the blood serum of rats with HIE. Methods: This study used an experimental post-test design in which occlusion of the right common carotid artery (CCA) was performed on Wistar rats, which were then placed in a hypoxic chamber and reperfused after 60 minutes (treatment group). Neurological scores were collected over the first 24 hours. After 48 hours, experimental animals were sacrificed and their serum NSE levels were measured using ELISA. Statistical analysis using a T-test was performed for independent samples. Results: A total of 16 male rats were included in the study. Neurological scores indicated that all HIE group rats experienced hemiparesis to varying degrees. NSE levels in the treatment group were significantly higher than in the control group (p < 0.05). The mean NSE level in the treatment group was higher than that in the other group. Conclusion: Consistent with in vitro studies, we found that NSE was higher in the HIE rat model than in controls. These data support future studies to assess the fitness of serum NSE as a biomarker of brain damage.